Can inflammation cause high ferritin?

Yes, inflammation can significantly elevate ferritin levels even without iron overload, as ferritin acts as an acute-phase reactant that increases during inflammatory conditions. This makes it crucial to test inflammatory markers like CRP alongside ferritin to accurately interpret results.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Ferritin-Inflammation Connection

Ferritin is commonly known as the primary storage protein for iron in your body, but its role extends far beyond simple iron storage. When inflammation strikes, ferritin levels can skyrocket regardless of your actual iron stores, creating a complex diagnostic picture that requires careful interpretation.

This dual nature of ferritin—as both an iron storage marker and an inflammatory marker—means that elevated ferritin doesn't always indicate iron overload. In fact, during inflammatory states, you might have high ferritin levels while simultaneously experiencing functional iron deficiency, a paradox that confuses many patients and even some healthcare providers.

Why Ferritin Rises During Inflammation

Ferritin as an Acute-Phase Reactant

Ferritin belongs to a group of proteins called acute-phase reactants, which increase rapidly in response to inflammation, infection, or tissue damage. When your immune system detects a threat, it triggers a cascade of inflammatory signals, including cytokines like interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). These cytokines stimulate liver cells to produce more ferritin, regardless of your body's iron status.

Interpreting Ferritin Levels with Other Iron and Inflammatory Markers

Clinical ScenarioFerritinCRP/hs-CRPTransferrin SaturationLikely Interpretation
Acute InflammationAcute InflammationHigh (>300 ng/mL)ElevatedNormal or Low (<45%)Inflammation-driven ferritin elevation
Iron OverloadIron OverloadHigh (>300 ng/mL)NormalHigh (>45%)True iron overload (consider hemochromatosis)
Iron DeficiencyIron DeficiencyLow (<30 ng/mL)NormalLow (<20%)Iron deficiency without inflammation
Anemia of InflammationAnemia of InflammationNormal or HighElevatedLow (<20%)Functional iron deficiency due to inflammation

This table helps distinguish between different causes of abnormal ferritin levels. Always consult with a healthcare provider for proper interpretation.

This inflammatory response serves an evolutionary purpose: by sequestering iron inside ferritin molecules, your body makes it less available to invading pathogens that need iron to survive and multiply. It's essentially a defense mechanism that has helped humans survive infections throughout history.

The Iron Sequestration Mechanism

During inflammation, your body activates a hormone called hepcidin, which acts as the master regulator of iron metabolism. Hepcidin blocks iron absorption in the gut and traps iron inside cells, particularly in macrophages and liver cells. This trapped iron gets stored in ferritin, causing ferritin levels to rise while the iron available for making red blood cells actually decreases.

This mechanism explains why many people with chronic inflammatory conditions develop what's called anemia of chronic disease or anemia of inflammation—they have plenty of stored iron (high ferritin) but can't use it effectively for essential functions like producing hemoglobin.

Common Inflammatory Conditions That Elevate Ferritin

Understanding which conditions can cause inflammatory ferritin elevation helps distinguish between true iron overload and inflammation-driven increases. Here are the most common culprits:

  • Autoimmune diseases (rheumatoid arthritis, lupus, inflammatory bowel disease)
  • Chronic infections (hepatitis, HIV, tuberculosis)
  • Metabolic conditions (obesity, metabolic syndrome, fatty liver disease)
  • Acute infections (COVID-19, pneumonia, urinary tract infections)
  • Cancer and its treatments
  • Chronic kidney disease
  • Alcohol-related liver disease

Even seemingly minor inflammatory triggers like a recent vaccination, intense exercise, or psychological stress can temporarily elevate ferritin levels. This is why timing your blood tests appropriately and considering recent health events is crucial for accurate interpretation.

Distinguishing Inflammatory Ferritin from Iron Overload

Key Laboratory Markers

To determine whether high ferritin reflects inflammation or true iron overload, healthcare providers look at a comprehensive panel of markers. Understanding these different biomarkers and their relationships is essential for accurate diagnosis.

The most important companion test to ferritin is C-reactive protein (CRP) or high-sensitivity CRP (hs-CRP). When both ferritin and CRP are elevated, inflammation is likely driving the ferritin increase. Conversely, if ferritin is high but CRP is normal, true iron overload becomes more probable.

The Transferrin Saturation Clue

Transferrin saturation provides crucial insight into whether iron overload is present. In inflammatory states, transferrin saturation typically remains normal or low (under 45%) despite high ferritin. In true iron overload conditions like hereditary hemochromatosis, transferrin saturation is usually elevated above 45%, often reaching 60-90%.

Regular monitoring of these markers together provides a more complete picture of your iron status and inflammatory state. This comprehensive approach helps avoid misdiagnosis and inappropriate treatment.

Clinical Implications of Inflammation-Driven High Ferritin

Treatment Considerations

When high ferritin is caused by inflammation rather than iron overload, the treatment approach differs dramatically. Iron reduction therapies like phlebotomy or chelation, which are appropriate for true iron overload, could actually worsen anemia in someone with inflammation-driven ferritin elevation.

Instead, treatment should focus on addressing the underlying inflammatory condition. This might involve anti-inflammatory medications, lifestyle modifications, or treating specific infections or autoimmune conditions. As inflammation resolves, ferritin levels typically normalize without any direct intervention targeting iron stores.

Monitoring Strategies

For individuals with chronic inflammatory conditions, regular monitoring becomes essential. Tracking ferritin alongside inflammatory markers helps distinguish disease flares from changes in iron status. This is particularly important for conditions like rheumatoid arthritis or inflammatory bowel disease, where both inflammation and true iron deficiency can occur simultaneously.

Natural Approaches to Managing Inflammatory Ferritin

While medical treatment of underlying conditions is often necessary, several lifestyle interventions can help reduce inflammation and normalize ferritin levels:

  • Anti-inflammatory diet rich in omega-3 fatty acids, colorful vegetables, and whole grains
  • Regular moderate exercise (avoiding overtraining, which can increase inflammation)
  • Stress management through meditation, yoga, or other relaxation techniques
  • Adequate sleep (7-9 hours nightly) to support immune regulation
  • Maintaining a healthy weight to reduce metabolic inflammation
  • Limiting alcohol consumption, which can trigger liver inflammation

These lifestyle modifications not only help normalize ferritin but also improve overall health outcomes and reduce the risk of chronic disease development.

When to Seek Medical Evaluation

High ferritin warrants medical evaluation when it exceeds normal ranges, typically above 200-300 ng/mL for women and 300-400 ng/mL for men. However, the context matters significantly. A ferritin of 400 ng/mL with elevated CRP during an acute infection might be less concerning than a ferritin of 300 ng/mL with normal inflammatory markers and high transferrin saturation.

Seek immediate evaluation if high ferritin is accompanied by symptoms like unexplained fatigue, joint pain, abdominal pain, or skin color changes. These could indicate either significant inflammation requiring treatment or true iron overload conditions like hemochromatosis.

The Importance of Comprehensive Testing

Given ferritin's dual role as an iron and inflammatory marker, comprehensive testing provides the clearest picture of your health status. A complete iron panel including ferritin, transferrin saturation, total iron binding capacity, and serum iron, combined with inflammatory markers like CRP, helps healthcare providers make accurate diagnoses and treatment decisions.

Regular monitoring becomes even more important if you have risk factors for either iron disorders or inflammatory conditions. Early detection and appropriate management can prevent complications and improve long-term health outcomes. Understanding your biomarkers empowers you to take control of your health and work effectively with your healthcare team.

Moving Forward with Ferritin Management

High ferritin due to inflammation is a common finding that requires thoughtful interpretation rather than knee-jerk treatment. By understanding the connection between inflammation and ferritin, you can work with your healthcare provider to identify underlying causes and develop appropriate treatment strategies. Remember that ferritin is just one piece of the puzzle—comprehensive testing and clinical context provide the full picture needed for optimal health management.

References

  1. Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev. 2009;23(3):95-104.[PubMed][DOI]
  2. Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014;6(4):748-773.[PubMed][DOI]
  3. Nemeth E, Ganz T. Anemia of inflammation. Hematol Oncol Clin North Am. 2014;28(4):671-681.[PubMed][DOI]
  4. Dignass A, Farrag K, Stein J. Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions. Int J Chronic Dis. 2018;2018:9394060.[PubMed][DOI]
  5. Camaschella C. Iron deficiency. Blood. 2019;133(1):30-39.[PubMed][DOI]
  6. Muckenthaler MU, Rivella S, Hentze MW, Galy B. A Red Carpet for Iron Metabolism. Cell. 2017;168(3):344-361.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ferritin at home?

You can test your ferritin at home with SiPhox Health's Core Health Program, which includes ferritin testing along with other essential biomarkers. The program also measures inflammatory markers like hs-CRP, helping you understand whether elevated ferritin is due to inflammation or iron overload.

What is considered a normal ferritin level?

Normal ferritin ranges vary by sex and laboratory, but typically fall between 12-150 ng/mL for women and 12-300 ng/mL for men. However, optimal levels are often narrower, around 50-150 ng/mL, as very low or high-normal values can indicate developing issues.

How long does it take for ferritin to normalize after inflammation resolves?

Ferritin levels typically begin decreasing within 2-4 weeks after acute inflammation resolves, but complete normalization can take 2-3 months. In chronic inflammatory conditions, ferritin may remain elevated as long as inflammation persists.

Can stress alone cause high ferritin levels?

While acute psychological stress typically doesn't cause significant ferritin elevation, chronic stress can trigger systemic inflammation that raises ferritin levels. Stress also affects sleep, diet, and exercise habits, which indirectly influence both inflammation and ferritin.

Should I avoid iron-rich foods if my ferritin is high due to inflammation?

If inflammation is causing high ferritin without true iron overload, restricting dietary iron isn't usually necessary and could worsen anemia of inflammation. Focus on anti-inflammatory foods instead, but consult your healthcare provider for personalized dietary guidance based on your complete iron panel results.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details